Printer Friendly

Medical Technology Announces Restructure of Private Placement

LANCASTER, Pa., Nov. 25 /PRNewswire/ -- Medical Technology & Innovations Inc. announced today they have restructured the convertible private placement. The new conversion features a fixed conversion price and a lock up period with a term of three years. The final terms of this conversion are subject to the approval of the Board of Directors.

Medical Technology & Innovations, Inc. manufactures and sells the MTI Photoscreener(TM), a hand-held photographic device used to screen the eyes of young, preverbal and difficult-to-screen children for Amblyopia or "Lazy Eye" Syndrome and other vision problems. The company has recently acquired Steridyne Corporation, a profitable manufacturer and distributor of pediatric and general health products, including fever monitoring devices, anti- decubitus gel cushions and disposables.

Please visit the web site at:

SOURCE Medical Technology & Innovations Inc.
 -0- 11/25/96

/CONTACT: Neil Rand or Deborah Lange, both of Corporate Imaging, 602-504-9230/


CO: Medical Technology & Innovations Inc. ST: Pennsylvania IN: MTC SU:

TT-DP -- LAM040 -- 3761 11/25/96 12:51 EST
COPYRIGHT 1996 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 25, 1996
Previous Article:United Airlines and Mexicana Airlines Announce Code Share Agreement
Next Article:/C O R R E C T I O N -- PPT VISION, INC./(Correction Notice)

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters